Similar articles for PMID: 30205115

Year	Number of Results
2002	2
2005	3
2006	2
2007	1
2009	5
2010	9
2011	8
2012	16
2013	12
2014	5
2015	13
2016	5
2017	6
2018	7
2019	6
2020	7
2021	8
2022	1
2024	2
2025	1

1

Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.

Xu Z, Zhang SY, Huang M, Hu R, Li JL, Cen HJ, Wang ZP, Ou JS, Yin SL, Xu YQ, Wu ZK, Zhang X. Xu Z, et al. Ann Thorac Surg. 2018 Dec;106(6):1774-1781. doi: 10.1016/j.athoracsur.2018.07.026. Epub 2018 Sep 8. Ann Thorac Surg. 2018. PMID: 30205115 Clinical Trial.

2

Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.

Kim HS, Lee SS, Oh M, Jang YJ, Kim EY, Han IY, Cho KH, Shin JG. Kim HS, et al. Pharmacogenet Genomics. 2009 Feb;19(2):103-12. doi: 10.1097/FPC.0b013e32831a9ae3. Pharmacogenet Genomics. 2009. PMID: 19077919

3

Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes.

Hao Y, Yang J, Zheng X, Hu Y, Yan X, Zhang L. Hao Y, et al. Ther Drug Monit. 2019 Dec;41(6):748-754. doi: 10.1097/FTD.0000000000000664. Ther Drug Monit. 2019. PMID: 31259883 Clinical Trial.

4

A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.

Sridharan K, Sivaramakrishnan G. Sridharan K, et al. J Clin Pharm Ther. 2021 Jun;46(3):640-648. doi: 10.1111/jcpt.13334. Epub 2020 Dec 21. J Clin Pharm Ther. 2021. PMID: 33346393

5

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodríguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS. Gage BF, et al. JAMA. 2017 Sep 26;318(12):1115-1124. doi: 10.1001/jama.2017.11469. JAMA. 2017. PMID: 28973620 Free PMC article. Clinical Trial.

6

A randomized trial of genotype-guided dosing of warfarin.

Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, Kesteven P, Christersson C, Wahlström B, Stafberg C, Zhang JE, Leathart JB, Kohnke H, Maitland-van der Zee AH, Williamson PR, Daly AK, Avery P, Kamali F, Wadelius M; EU-PACT Group. Pirmohamed M, et al. N Engl J Med. 2013 Dec 12;369(24):2294-303. doi: 10.1056/NEJMoa1311386. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251363 Free article. Clinical Trial.

7

Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.

Makar-Aušperger K, Krželj K, Lovrić Benčić M, Radačić Aumiler M, Erdeljić Turk V, Božina N. Makar-Aušperger K, et al. Ther Drug Monit. 2018 Jun;40(3):362-368. doi: 10.1097/FTD.0000000000000501. Ther Drug Monit. 2018. PMID: 29494423 Clinical Trial.

8

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.

Syn NL, Wong AL, Lee SC, Teoh HL, Yip JWL, Seet RC, Yeo WT, Kristanto W, Bee PC, Poon LM, Marban P, Wu TS, Winther MD, Brunham LR, Soong R, Tai BC, Goh BC. Syn NL, et al. BMC Med. 2018 Jul 10;16(1):104. doi: 10.1186/s12916-018-1093-8. BMC Med. 2018. PMID: 29986700 Free PMC article. Clinical Trial.

9

Genetic and clinical determinants influencing warfarin dosing in children with heart disease.

Nguyen N, Anley P, Yu MY, Zhang G, Thompson AA, Jennings LJ. Nguyen N, et al. Pediatr Cardiol. 2013 Apr;34(4):984-90. doi: 10.1007/s00246-012-0592-1. Epub 2012 Nov 25. Pediatr Cardiol. 2013. PMID: 23183958

10

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients.

Huang SW, Chen HS, Wang XQ, Huang L, Xu DL, Hu XJ, Huang ZH, He Y, Chen KM, Xiang DK, Zou XM, Li Q, Ma LQ, Wang HF, Chen BL, Li L, Jia YK, Xu XM. Huang SW, et al. Pharmacogenet Genomics. 2009 Mar;19(3):226-34. doi: 10.1097/FPC.0b013e328326e0c7. Pharmacogenet Genomics. 2009. PMID: 19177029 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 30205115

101 results

Results by year